Publications by authors named "F Schuetz"

Claim this Profile
A
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, Nina Ditsch, Tanja Fehm, Florian Schuetz

Eur J Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Automated ELISA for potency measurements of therapeutic antibodies and antibody fragments" [J. Pharm. Biomed. Anal. 245 (2024) 116141].
Guillaume Rey, Fabienne Schuetz, Daniela Schroeder, Christian Kaluschke, Markus W Wendeler

J Pharm Biomed Anal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER breast cancer.
Philipp Zimmer, Tobias Esser, Diana Lueftner, Florian Schuetz, Freerk T Baumann

BMC Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated ELISA for potency measurements of therapeutic antibodies and antibody fragments.
Guillaume Rey, Fabienne Schuetz, Daniela Schroeder, Christian Kaluschke, Markus W Wendeler

J Pharm Biomed Anal· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Diana Lüftner, Florian Schuetz, Andreas Schneeweiss, Andreas Hartkopf, Wilhelm Bloch

Int J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis